DISEASE INDICATIONS: Multiple Myeloma

MANUFACTURER: Takeda Pharma A/S

USAGE: Oral

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Health Canada

Pharmaceuticals and Medical Devices Agency (PMDA)

Therapeutic Goods Administration (TGA)

Ninlaro (ixazomib) is a medication used in combination with lenalidomide and dexamethasone to treat people with multiple myeloma who have undergone one to three previous lines of therapy.